Ana De Jesus-Acosta

Assistant Professor

20082019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Ana De Jesus-Acosta is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Pancreatic Neoplasms Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Survival Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
irinotecan Medicine & Life Sciences
Neuroendocrine Tumors Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2019

Effect of Gemcitabine and nab-Paclitaxel with or Without Hydroxychloroquine on Patients with Advanced Pancreatic Cancer: A Phase 2 Randomized Clinical Trial

Karasic, T. B., O'Hara, M. H., Loaiza-Bonilla, A., Reiss, K. A., Teitelbaum, U. R., Borazanci, E., De Jesus-Acosta, A., Redlinger, C., Burrell, J. A., Laheru, D., Von Hoff, D. D., Amaravadi, R. K., Drebin, J. A. & O'Dwyer, P. J., Jan 1 2019, In : JAMA Oncology.

Research output: Contribution to journalArticle

gemcitabine
Hydroxychloroquine
Pancreatic Neoplasms
Randomized Controlled Trials
Sulfates
Adenocarcinoma
Cell Death
Ligands
Survival
Biomarkers

The Molecular and Clinical Landscape of Pancreatic Neuroendocrine Tumors

Batukbhai, B. D. O. & De Jesus-Acosta, A., Jan 1 2019, In : Pancreas. 48, 1, p. 9-21 13 p.

Research output: Contribution to journalReview article

Neuroendocrine Tumors
Neoplasms
Pancreatic Neoplasms
Islets of Langerhans
Molecular Biology

The Significance of Ascites in Patients with Pancreatic Ductal Adenocarcinoma: A Case-Control Study

Baretti, M., Pulluri, B., Tsai, H. L., Blackford, A. L., Wolfgang, C., Laheru, D., Zheng, L., Herman, J., Le, D., Narang, A. & De Jesus-Acosta, A., Apr 1 2019, In : Pancreas. 48, 4, p. 585-589 5 p.

Research output: Contribution to journalArticle

Ascites
Case-Control Studies
Adenocarcinoma
Confidence Intervals
Survival

A phase I trial of a guadecitabine (SGI-110) and irinotecan in metastatic colorectal cancer patients previously exposed to irinotecan

Lee, V., Wang, J., Zahurak, M., Gootjes, E., Verheul, H. M., Parkinson, R., Kerner, Z., Sharma, A., Rosner, G., De Jesus-Acosta, A., Laheru, D., Le, D., Oganesian, A., Lilly, E., Brown, T., Jones, P., Baylin, S. B., Ahuja, N. & Azad, N., Dec 15 2018, In : Clinical Cancer Research. 24, 24, p. 6160-6167 8 p.

Research output: Contribution to journalArticle

irinotecan
Colorectal Neoplasms
Intercellular Signaling Peptides and Proteins
Fever
Gastrointestinal Neoplasms